SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 61 filers reported holding SIERRA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,000 | -46.6% | 79,671 | -23.3% | 0.01% | -42.9% |
| Q2 2019 | $58,000 | -58.0% | 103,911 | +28.6% | 0.02% | -73.4% |
| Q1 2019 | $138,000 | -70.1% | 80,799 | -76.9% | 0.08% | -38.8% |
| Q4 2018 | $461,000 | -31.2% | 349,258 | -11.4% | 0.13% | -10.4% |
| Q3 2018 | $670,000 | +57.3% | 394,258 | +173.8% | 0.14% | +63.6% |
| Q2 2018 | $426,000 | +769.4% | 143,991 | +512.2% | 0.09% | +877.8% |
| Q1 2018 | $49,000 | – | 23,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $9,491,000 | 4.86% |
| New Leaf Venture Partners, L.L.C. | 2,744,088 | $3,211,000 | 2.26% |
| DAFNA Capital Management LLC | 265,000 | $310,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,495,734 | $4,090,000 | 0.22% |
| Perceptive Advisors | 3,655,186 | $4,277,000 | 0.22% |
| NEXTHERA CAPITAL LP | 400,000 | $468,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 1,662,487 | $1,945,000 | 0.13% |
| AWM Investment Company, Inc. | 500,000 | $585,000 | 0.10% |
| VHCP Management II, LLC | 130,798 | $153,000 | 0.06% |
| Orbimed Advisors | 3,703,704 | $4,333,000 | 0.04% |